Premium Subscribers: Complete your KYC to Avoid
Service Suspension. Login Here.

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

THYROCARE TECHNOLOGIES Plunges 6%; BSE HEALTHCARE Index Down 0.4%
Wed, 3 Dec 9:49

THYROCARE TECHNOLOGIES Plunges 6%; BSE HEALTHCARE Index Down 0.4%Image source: Nikada/www.istockphoto.com

THYROCARE TECHNOLOGIES share price has plunged 6% and is presently trading at Rs 437.9.

Meanwhile, the BSE HEALTHCARE index is at 44,412.1 (down 0.4%).

Among the top losers in the BSE HEALTHCARE index today are MAX HEALTHCARE INSTITUTE (down 1.7%) and GSK Pharma (down 1.4%).

SUN PHARMA ADV. RES. (up 11.1%) and Biocon (up 1.4%) are among the top gainers today.

Over the last one year, THYROCARE TECHNOLOGIES has moved up from Rs 345.6 to Rs 437.9, registering a gain of Rs 92.2 (up 26.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 44,196.0 to 44,412.1, registering a gain of 0.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were LAURUS LABS (up 75.6%), NARAYANA HRUDAYALAYA (up 52.1%) and ASTRAZENECA PHARMA (up 35.1%).

Must See: Should You Sell? Hold? Or Buy the Dip?

What About the Benchmark Indices?

The BSE Sensex is at 84,893.6 (down 0.3%).

The top losers among the BSE Sensex today are Hindustan Unilever (down 1.9%) and Nestle (down 1.3%). The most traded stocks in the BSE Sensex are ITC and SBI.

In the meantime, NSE Nifty is at 25,943.9 (down 0.3%). Shriram Transport and Hindustan Unilever are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 80,248.1 to 84,893.6, registering a gain of 4,645.5 points (up 5.8%).

THYROCARE TECHNOLOGIES Financial Update...

THYROCARE TECHNOLOGIES net profit grew 77.9% YoY to Rs 475 million for the quarter ended September 2025, compared to a profit of Rs 267 million a year ago. Net sales rose 22.1% to Rs 2,165 million during the period as against Rs 1,774 million in July-September 2024.

For the year ended March 2025, THYROCARE TECHNOLOGIES reported 30.6% increase in net profit to Rs 908 million compared to net profit of Rs 695 million during FY24. Revenue of the company grew 20.2% to Rs 6,874 million during FY25.

The current Price to earnings ratio of THYROCARE TECHNOLOGIES, based on rolling 12 month earnings, stands at 54.9.


Equitymaster requests your view! Post a comment on "THYROCARE TECHNOLOGIES Plunges 6%; BSE HEALTHCARE Index Down 0.4%". Click here!